Argentina Genome Editing Market Size & Outlook, 2024-2030

The genome editing market in Argentina is expected to reach a projected revenue of US$ 140.2 million by 2030. A compound annual growth rate of 13.6% is expected of Argentina genome editing market from 2025 to 2030.
Revenue, 2024 (US$M)
$65.3
Forecast, 2030 (US$M)
$140.2
CAGR, 2025 - 2030
13.6%
Report Coverage
Argentina

Argentina genome editing market highlights

  • The Argentina genome editing market generated a revenue of USD 54.6 million in 2023 and is expected to reach USD 140.2 million by 2030.
  • The Argentina market is expected to grow at a CAGR of 14.4% from 2024 to 2030.
  • In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2023.
  • (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.


Genome editing market data book summary

Market revenue in 2023USD 54.6 million
Market revenue in 2030USD 140.2 million
Growth rate14.4% (CAGR from 2023 to 2030)
Largest segment(crispr)/cas9
Fastest growing segment(CRISPR)/Cas9
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentation(CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease
Key market players worldwideMerck KGaA, Cibus Inc Ordinary Shares - Class A, Recombinetics, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision BioSciences Inc, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origene Technologies, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc


Other key industry trends

  • In terms of revenue, Argentina accounted for 0.7% of the global genome editing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil genome editing market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 660.7 million by 2030.

(crispr)/cas9 was the largest segment with a revenue share of 46.15% in 2024. Horizon Databook has segmented the Argentina genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2018 to 2030.


Argentina's genome editing market is driven by factors such as the presence of a rich agricultural heritage and strong expertise in biotechnology that is fueling innovation in genetic engineering for crop improvement, supportive government policies, and investments in R&D to encourage the adoption of advanced genetic technologies, and a growing demand for sustainable agriculture and bio-based solutions. In addition, collaborations among academia, industry, and government foster knowledge exchange & technology transfer, boosting market growth.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Genome Editing Market Companies

Name Profile # Employees HQ Website

Argentina genome editing market size, by technology, 2018-2030 (US$M)

Argentina Genome Editing Market Outlook Share, 2024 & 2030 (US$M)

Argentina genome editing market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more